(Don't) Be Still My Beating Heart | GenomeWeb

At the Association for Molecular Pathology's annual meeting in San Jose last week, Harvard Medical School's Jonathan Seidman made a case for the importance of studying rare genetic variants that cause cardiomyopathy. Various genes cause different pathway mutations that lead to cardiomyopathy, Seidman said, and cardiologists can't distinguish between them. While there are several common variants, there are multiple rare variants that can significantly increase a patient's chances of suffering from the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

Diversity Needed

This Week in PNAS

This Week in Cell

Spot for Information

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.